z-logo
Premium
Bempedoic acid for primary hypercholesterolaemia
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1888
Subject(s) - medicine , primary (astronomy) , physics , astronomy
Bempedoic acid (Nilemdo) is a new lipid‐lowering therapy for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia. This article summarises its mechanism of action, clinical trial efficacy and side‐effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here